Cargando…
Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy
Aim: Co-encapsulation of anti-cancer agents in pegylated liposomes may provide an effective tool to maximize efficacy of combined drug therapy by taking advantage of the long circulation time, passive targeting, and reduced toxicity of liposome formulations. Methods: We have developed several liposo...
Autores principales: | Gabizon, Alberto, Ohana, Patricia, Amitay, Yasmine, Gorin, Jenny, Tzemach, Dina, Mak, Lidia, Shmeeda, Hilary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019273/ https://www.ncbi.nlm.nih.gov/pubmed/35582027 http://dx.doi.org/10.20517/cdr.2020.87 |
Ejemplares similares
-
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023) -
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients
por: Golan, Talia, et al.
Publicado: (2015) -
Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts
por: Christensen, Esben, et al.
Publicado: (2018) -
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
por: Islam, Md. Rakibul, et al.
Publicado: (2022) -
Exploiting
the Metal-Chelating Properties of the Drug
Cargo for In Vivo Positron Emission Tomography Imaging
of Liposomal Nanomedicines
por: Edmonds, Scott, et al.
Publicado: (2016)